IOL DESIGN CHALLENGES REMAIN IN ADDRESSING DYSPHOTOPSIAS

Arthur Cummings
Published: Saturday, September 5, 2015
Dysphotopsias remain an issue to be solved by next-generation intraocular lenses (IOLs) or by more rigorous IOL selection based on dysphotopsia diagnostics, Patricia Piers PhD, the Netherlands, told a Clinical Research Symposium at the XXXIII Congress of the ESCRS yesterday.
“There is still a lot of discussion on the causes of and solution for negative dysphotopsia. The causes may be multifactorial and trade-offs are involved with almost all potential solutions,” she said.
Defining dysphotopsia as subjectively reported, bothersome light-related phenomena associated with uncomplicated cataract or IOL surgery, Dr Piers said it can be further subdivided into three main categories: positive dysphotopsia (bright arcs, streaks or flashes, starbursts); negative dysphotopsia (dark arcs or shadows); and multifocal positive dysphotopsia (halos, glare, starbursts, rings, night vision problems).
Reported rates of positive and negative dysphotopsia vary from 10 to 20 per cent on day one postoperatively, reducing to two to three per cent at follow-up points ranging from one month to one year. The reported exchange or explantation rate is about 0.13 per cent, she said.
For multifocal dysphotopsia, there are spontaneous reports of severe halos, glare, starbursts and night vision problems in one per cent to nine per cent of cases at six months postoperatively, with the rate dependent on IOL design.
Looking at the measures taken by IOL manufacturers to address these problems, Dr Piers cited innovations such as the introduction of round anterior edge designs, reduced edge thickness, frosted edge, altered power ratios and lower refractive index materials.
Such modifications invariably involve some trade-offs – such as anterior or posterior capsule opacification, IOL stability or larger incisions – that need to be assessed carefully in the overall performance of the lens, said Dr Piers.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.